Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
4
×
biogen
4
×
glaxosmithkline
4
×
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
4
×
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
clinical trials
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
merck
pfizer
roche
abbvie
adverum biotechnologies
alzheimer's disease
cancer immunotherapy
What
bio
roundup
crispr
days
drug
acquisitions
advanced
albert
alliance
arrival
august
award
biggest
biotech
bourla
bristol
busy
buy
calls
cancer
ceo
changing
color
company
data
death
decades
decisions
dems
devices
drugs
fda
future
given
growing
hours
immunotherapy
imports
kudos
leaves
Language
unset
unknown
Current search:
amgen
×
glaxosmithkline
×
" seattle blog main "
×
biogen
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
4 years ago
Bio Roundup: Award Winners, Lung Data, Dems on Drug Pricing & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More